SLS
Sellas Life Sciences Group Inc.
$13.19
▲ +12.26%
+$1.44
NASDAQ · Healthcare · Biotechnology
today's anomalySellas Life Sciences Group Inc.
today's anomalySLS · NASDAQ · Healthcare · Biotechnology
$13.19
▲ +12.26% · +$1.44 today
fundamentals65.5 /100 vs peers · 65% coverage
strong
4 of 5 metrics · 80% coverage
Revenue growth (TTM)
No Revenue growth (TTM) dataSector 5Y avg: 14.1
EPS growth (TTM)41.6
262% above Sector 5Y avg avg · favorableSector 5Y avg: 11.5
EPS forecast (5Y)50.7
250% above Sector fwd avg avg · favorableSector fwd avg: 14.5
EPS next year28.6
strong pace
EPS growth (Q/Q)26.4
strong pace
Missing inputs are treated as neutral uncertainty; compared with sector peers where available.
vs sector peers
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| SLSSellas Life Sciences Group Inc. | $2.59B | - | - | 66 |
| GMEDGlobus Medical | $10.60B | 18.2 | +23.5% | 78 |
| INDVIndivior | $4.94B | 20.5 | +10.3% | 78 |
| DXCMDexcom | $28.93B | 32.1 | +16.1% | 77 |
| LLYEli Lilly and Company | $1.12T | 42.8 | +47.4% | 76 |
